Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.00
+0.10 (0.30%)
Jun 3, 2026, 1:30 PM CST
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 710.42 million as of June 3, 2026. Its market cap has increased by 0.30% in one year.
Market Cap
710.42M
Enterprise Value
621.38M
Revenue
382.82M
Ranking
n/a
PE Ratio
84.70
Stock Price
33.00
Market Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 710.42M, a decrease of -58.19%. That is a compound annual growth rate of -8.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 712.58M | 9.45% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.34B |
| DIVA Laboratories | 1.84B |
| Puriblood Medical | 1.26B |
| Genetics Generation Advancement | 1.08B |
| Kim Forest Enterprise | 724.46M |
| TFBS Bioscience | 714.51M |
| Pharmigene | 403.72M |
| Welgene Biotech | 377.53M |